A Randomized, Controlled, Split-Face, Double-Blind Study Comparing Topical Malassezin to Hydroquinone 4% for Melasma
Journal of Drugs in Dermatology · 2026
DOI: 10.36849/jdd.9222 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Drugs in Dermatology, 2026. Verfasst von Pearl E Grimes und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Hydroquinones, Melanosis, Dermatologic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Grimes, P. E., Dias, S., Oparaugo, N. C., Tatarinova, T., & McCraw, T. (2026). A Randomized, Controlled, Split-Face, Double-Blind Study Comparing Topical Malassezin to Hydroquinone 4% for Melasma. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.9222
Vancouver
Grimes PE, Dias S, Oparaugo NC, Tatarinova T, McCraw T. A Randomized, Controlled, Split-Face, Double-Blind Study Comparing Topical Malassezin to Hydroquinone 4% for Melasma. Journal of Drugs in Dermatology. 2026. doi:10.36849/jdd.9222
BibTeX
@article{Grimes2026,
author = {Grimes, Pearl E and Dias, Shanaya and Oparaugo, Nicole Chizara and Tatarinova, Tatiana and McCraw, Tim},
title = {A Randomized, Controlled, Split-Face, Double-Blind Study Comparing Topical Malassezin to Hydroquinone 4% for Melasma},
journal = {Journal of Drugs in Dermatology},
year = {2026},
doi = {10.36849/jdd.9222}
}
EUVIMED